Arovella Therapeutics (ASX:ALA) has successfully manufactured and passed quality release testing for its lead product ALA-101 | ASX Announcement: https://announcements.asx.com.au/asxpdf/20240102/pdf/05z33l2t26k412.pdf #ALA #Cancer
ASR
0.002
100%
MHK
0.17
-54.1%
WEL
0.002
100%
ECT
0.002
-33.3%
ALM
0.006
50%
SER
0.005
-28.6%
IS3
0.012
33.3%
XPN
0.008
-27.3%
YAR
0.014
27.3%
AQC
0.009
-25%
C1X
0.082
26.2%
CHM
0.003
-25%
DDT
0.005
25%
MEM
0.003
-25%
NVQ
0.047
23.7%
CTT
0.267
-21.5%
XRG
0.033
22.2%
3DP
0.045
-21.1%
AAU
0.006
20%
MVP
0.55
-19.7%
AVE
0.006
20%
IR1
0.09
-18.2%
FAU
0.006
20%
GRE
0.066
-17.5%
FBR
0.006
20%
BNL
0.005
-16.7%
I88
0.15
20%
ASE
0.021
-16%
X2M
0.019
18.8%
MAG
0.043
-15.7%
SRL
1.24
18.1%
MQR
0.011
-15.4%
CHR
0.059
18%
NYM
0.039
-15.2%
DRO
3.705
16.9%
LML
0.006
-14.3%
PPK
0.66
16.8%
USL
0.372
-13.5%
TMS
0.007
16.7%
KRR
0.007
-12.5%
